Genpact's Competitive Landscape and Stock Performance Genpact is recognized as a leader in business process outsourcing, facing competition from CACI International. While analysts favor CACI for its stronger consensus rating, Genpact holds a significant position with higher earnings and institutional ownership but lacks in revenue and profitability compared to CACI. Genpact's diverse offerings span financial services, consumer healthcare, and high-tech manufacturing, yet CACI's focus on national security makes it a strong contender.
Despite a recent stock decline of 0.88% to USD 37.26, Wall Street Zen upgraded Genpact's stock from Hold to Buy, with a target price of USD 39.33, suggesting potential upside. With a market cap of USD 6.3 billion and a P/E ratio of 11.06, Genpact's upcoming third-quarter results on November 5, 2026, will be pivotal for investor sentiment. |
